Glycemia in newborns of hypertensive mothers according to maternal treatment

PURPOSE: To evaluate the evolution of glycemic levels in newborns of hypertensive mothers according to maternal treatment. METHODS: Prospective randomized study, including 93 newborns of mothers treated with isradipine (n = 39), atenolol (n = 40), or low sodium diet (control group - n=14). Glycemia was determined at birth (mother and newborn by the oxidase glucose method) and in the 1st, 3rd, 6th, 12th, and 24th hours after birth (newborn by a test strip method). The evolution of glycemia was analyzed in each group (Friedman test). The groups were compared regarding glycemia (Kruskall-Wallis test), and linear regression models were constructed for the analyses (independent variable = maternal glycemia; dependent variables = umbilical cord, 3rd, and 6th hour glycemia). RESULTS: There were no statistically significant differences among the mean blood glucose levels of the 3 groups in any of the assessments. There was a correlation between maternal and umbilical cord blood glucose in the isradipine (r = 0.61; P <.05) and control (r = 0.84; P <.05) groups. Regarding glycemia levels of the mothers and newborns in the third and sixthhours postpartum, this correlation was present only in the control group (maternal x third hour: r = 0.65; P <.05; maternal x sixth hour: r = 0.68; P <.05). There were no correlations in the atenolol group. Hypoglycemia was detected in 51.3% of the isradipine group, 60% of the atenolol group, and 35.7% of the control group, and it was more frequent in the first hour postpartum in all groups. CONCLUSIONS: The results suggest a similar effect of the 3 types of treatment upon newborn glycemia. The correlation analysis suggests that isradipine could have effects upon newborn glycemia only after birth (correlation only in umbilical cord blood), whereas atenolol could act earlier (there was no correlation at any moment). The results also point to the need for glycemic control from the first hour postpartum of newborns of hypertensive mothers whether they have or have not undergone treatment with antihypertensive drugs.

Saved in:
Bibliographic Details
Main Authors: Darcie,Silvana, Leone,Cléa R., Calil,Valdenise M. L. T., Prescinotti,Elizete P., Kahhale,Soubhi, Zugaib,Marcelo
Format: Digital revista
Language:English
Published: Faculdade de Medicina / Universidade de São Paulo - FM/USP 2004
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000500004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0041-87812004000500004
record_format ojs
spelling oai:scielo:S0041-878120040005000042004-10-29Glycemia in newborns of hypertensive mothers according to maternal treatmentDarcie,SilvanaLeone,Cléa R.Calil,Valdenise M. L. T.Prescinotti,Elizete P.Kahhale,SoubhiZugaib,Marcelo Hypertension Pregnancy Glycemia Hypoglycemia PURPOSE: To evaluate the evolution of glycemic levels in newborns of hypertensive mothers according to maternal treatment. METHODS: Prospective randomized study, including 93 newborns of mothers treated with isradipine (n = 39), atenolol (n = 40), or low sodium diet (control group - n=14). Glycemia was determined at birth (mother and newborn by the oxidase glucose method) and in the 1st, 3rd, 6th, 12th, and 24th hours after birth (newborn by a test strip method). The evolution of glycemia was analyzed in each group (Friedman test). The groups were compared regarding glycemia (Kruskall-Wallis test), and linear regression models were constructed for the analyses (independent variable = maternal glycemia; dependent variables = umbilical cord, 3rd, and 6th hour glycemia). RESULTS: There were no statistically significant differences among the mean blood glucose levels of the 3 groups in any of the assessments. There was a correlation between maternal and umbilical cord blood glucose in the isradipine (r = 0.61; P <.05) and control (r = 0.84; P <.05) groups. Regarding glycemia levels of the mothers and newborns in the third and sixthhours postpartum, this correlation was present only in the control group (maternal x third hour: r = 0.65; P <.05; maternal x sixth hour: r = 0.68; P <.05). There were no correlations in the atenolol group. Hypoglycemia was detected in 51.3% of the isradipine group, 60% of the atenolol group, and 35.7% of the control group, and it was more frequent in the first hour postpartum in all groups. CONCLUSIONS: The results suggest a similar effect of the 3 types of treatment upon newborn glycemia. The correlation analysis suggests that isradipine could have effects upon newborn glycemia only after birth (correlation only in umbilical cord blood), whereas atenolol could act earlier (there was no correlation at any moment). The results also point to the need for glycemic control from the first hour postpartum of newborns of hypertensive mothers whether they have or have not undergone treatment with antihypertensive drugs.info:eu-repo/semantics/openAccessFaculdade de Medicina / Universidade de São Paulo - FM/USPRevista do Hospital das Clínicas v.59 n.5 20042004-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000500004en10.1590/S0041-87812004000500004
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Darcie,Silvana
Leone,Cléa R.
Calil,Valdenise M. L. T.
Prescinotti,Elizete P.
Kahhale,Soubhi
Zugaib,Marcelo
spellingShingle Darcie,Silvana
Leone,Cléa R.
Calil,Valdenise M. L. T.
Prescinotti,Elizete P.
Kahhale,Soubhi
Zugaib,Marcelo
Glycemia in newborns of hypertensive mothers according to maternal treatment
author_facet Darcie,Silvana
Leone,Cléa R.
Calil,Valdenise M. L. T.
Prescinotti,Elizete P.
Kahhale,Soubhi
Zugaib,Marcelo
author_sort Darcie,Silvana
title Glycemia in newborns of hypertensive mothers according to maternal treatment
title_short Glycemia in newborns of hypertensive mothers according to maternal treatment
title_full Glycemia in newborns of hypertensive mothers according to maternal treatment
title_fullStr Glycemia in newborns of hypertensive mothers according to maternal treatment
title_full_unstemmed Glycemia in newborns of hypertensive mothers according to maternal treatment
title_sort glycemia in newborns of hypertensive mothers according to maternal treatment
description PURPOSE: To evaluate the evolution of glycemic levels in newborns of hypertensive mothers according to maternal treatment. METHODS: Prospective randomized study, including 93 newborns of mothers treated with isradipine (n = 39), atenolol (n = 40), or low sodium diet (control group - n=14). Glycemia was determined at birth (mother and newborn by the oxidase glucose method) and in the 1st, 3rd, 6th, 12th, and 24th hours after birth (newborn by a test strip method). The evolution of glycemia was analyzed in each group (Friedman test). The groups were compared regarding glycemia (Kruskall-Wallis test), and linear regression models were constructed for the analyses (independent variable = maternal glycemia; dependent variables = umbilical cord, 3rd, and 6th hour glycemia). RESULTS: There were no statistically significant differences among the mean blood glucose levels of the 3 groups in any of the assessments. There was a correlation between maternal and umbilical cord blood glucose in the isradipine (r = 0.61; P <.05) and control (r = 0.84; P <.05) groups. Regarding glycemia levels of the mothers and newborns in the third and sixthhours postpartum, this correlation was present only in the control group (maternal x third hour: r = 0.65; P <.05; maternal x sixth hour: r = 0.68; P <.05). There were no correlations in the atenolol group. Hypoglycemia was detected in 51.3% of the isradipine group, 60% of the atenolol group, and 35.7% of the control group, and it was more frequent in the first hour postpartum in all groups. CONCLUSIONS: The results suggest a similar effect of the 3 types of treatment upon newborn glycemia. The correlation analysis suggests that isradipine could have effects upon newborn glycemia only after birth (correlation only in umbilical cord blood), whereas atenolol could act earlier (there was no correlation at any moment). The results also point to the need for glycemic control from the first hour postpartum of newborns of hypertensive mothers whether they have or have not undergone treatment with antihypertensive drugs.
publisher Faculdade de Medicina / Universidade de São Paulo - FM/USP
publishDate 2004
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0041-87812004000500004
work_keys_str_mv AT darciesilvana glycemiainnewbornsofhypertensivemothersaccordingtomaternaltreatment
AT leoneclear glycemiainnewbornsofhypertensivemothersaccordingtomaternaltreatment
AT calilvaldenisemlt glycemiainnewbornsofhypertensivemothersaccordingtomaternaltreatment
AT prescinottielizetep glycemiainnewbornsofhypertensivemothersaccordingtomaternaltreatment
AT kahhalesoubhi glycemiainnewbornsofhypertensivemothersaccordingtomaternaltreatment
AT zugaibmarcelo glycemiainnewbornsofhypertensivemothersaccordingtomaternaltreatment
_version_ 1756380813145931776